Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Quinolone tolerances

Patients allergic to /3-lactams should receive a quinolone. Persons unable to tolerate a /3-lactam (penicillin or cephalosporin) or a quinolone should receive spectinomycin. [Pg.511]

Further development in the chemistry of oxazolidinone antibacterials was based mainly on the assumption that the 4-pyridyl moiety of one of Dupont s lead compounds, E-3709, might be amenable to replacement by suitably saturated heterocyclic bioisosteres [48]. This assumption was based on an example in which successful replacement of the piperazine ring system in the quinolone antibacterials, such as ciprofloxacin, with a pyridine fragment, such as seen in Win-57273, results in improvement of both the antibacterial and the pharmacokinetic profiles of the compounds. Similarly, as in the case of ciprofloxacin and Win-57273, it was predicted that the presence of a small but highly electron-withdrawing fluorine atom would be tolerated at the meta position(s) of the central phenyl ring, and would confer enhanced antibacterial activity and/or other desirable properties to the targeted oxazolidinones, as shown in Fig. 3. [Pg.188]

Although ciprofloxacin for oral and intravenous administration already displayed a very high standard of antibacterial activity and tolerance, some properties still required optimization. These included the need for improved activity against Gram-positive pathogens (e.g., S. pneumoniae) and anaerobic bacteria, and kinetic properties allowing once-daily administration. The properties required by Bayer of the third-generation quinolones were therefore as follows. [Pg.320]

The 3-aminomethyl-l-pyrrolidinyl radical, which was considered to be bioiso-steric to piperazine [91], also produced highly active quinolones, which were however also found not to be tolerated. In trovafloxacin 16 [92], the 3-aminomethyl-l-pyrrolidinyl radical is integrated into a bicydic amine structural unit with a free amino group [(la,5a,6a)-6-amino-3-azabicyclo[3.1.0]hexane]. A correlation probably exists between the increased central nervous system (CNS) side effects obtained with this quinolone [93] and the 2,4-difluorophenyl radical in the 1-posi-tion. Severe hepatic intolerance reactions finally resulted in major restrictions on its use, which was then limited in the USA to severe clinical infections [68]. [Pg.322]

The introduction of the free primary amino group of amino- or aminomethyl-pyrrolidinyl quinolones into nonfused ring systems produced active compounds which were highly active but not tolerated [105-107] (Fig. 14.9). [Pg.325]

Examples of quinolones in which the 7-(3-amino-l-pyrrolidinyl) radical or the 7-(3-aminomethyl-l-pyrrolidinyl) radical is substituted by a ring fused via the 3,4-position are those listed in Fig. 14.11 (cf. also Ref. [109]) and Fig. 14.12 [109,110]. Despite their powerful in vitro and in vivo activities, most of the quinolones containing such amine structural units have problems of tolerance. [Pg.325]

Stass H, et al. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrob. Agents Chemother., 1998, 42, 2060-2065. [Pg.367]

Patients allergic to 6-lactams should receive a quinolone. Persons unable to tolerate a 6-lactam (penicillin or cephalosporin) or a quinolone should receive spectinomycin. Also recommended for the treatment of uncomplicated infections of the pharynx in combination with a treatment regimen for presumptive C. trachomatis infection fluoroquinolones are not recommended for treating infections in MSM or infections acquired in Hawaii, California, or other parts of the world where high-level resistance to fluoroquinolones is reported. [Pg.2101]

A 44-year-old woman, who had previously tolerated moxifloxacin, developed pmritus, urticaria, and angioedema 10 minutes after a dose of moxifloxacin [IV j. Skin tests were performed with various quinolones and only the intradermal test with moxifloxacin was positive. She tolerated an oral challenge with... [Pg.401]

Cacchi and co-workers reported the synthesis of 1,2-disubstituted 4-quinolones via copper-catalyzed cyelization of l-(2-halophenyl)-2-en-3-amin-l-ones in 2009. Here, the l-(2-bromophenyl)- and l-(2-chloro-phenyl)-2-en-3-amin-l-ones were prepared from allynones and primary amines. The reaction tolerates a variety of useful functionalities including ester, keto, cyano, and chloro substituents. Good to excellent of the desired products were formed (Scheme 3.64a). One year later, Xu and Zhao developed a palladium-catalyzed procedure that could directly use o-haloaryl acetylenic ketones and primary amines (Scheme 3.64b). ... [Pg.241]


See other pages where Quinolone tolerances is mentioned: [Pg.456]    [Pg.237]    [Pg.278]    [Pg.193]    [Pg.521]    [Pg.178]    [Pg.425]    [Pg.319]    [Pg.329]    [Pg.352]    [Pg.355]    [Pg.425]    [Pg.2233]    [Pg.166]    [Pg.362]    [Pg.129]    [Pg.1902]    [Pg.399]    [Pg.72]    [Pg.456]    [Pg.140]    [Pg.129]    [Pg.76]    [Pg.94]    [Pg.401]    [Pg.401]    [Pg.1235]    [Pg.220]    [Pg.221]    [Pg.221]    [Pg.224]    [Pg.224]    [Pg.203]    [Pg.235]    [Pg.94]    [Pg.521]    [Pg.107]    [Pg.329]    [Pg.311]    [Pg.370]   
See also in sourсe #XX -- [ Pg.89 , Pg.251 ]




SEARCH



Quinolone

Quinolones

© 2024 chempedia.info